GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Pitx1 | rn6_v1_chr17_+_8878270_8878270 | 0.49 | 7.0e-21 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_224824799 Show fit | 44.24 |
ENSRNOT00000024757
|
solute carrier family 22 member 6 |
|
chr10_+_53818818 Show fit | 29.09 |
ENSRNOT00000057260
|
myosin heavy chain 8 |
|
chr20_+_20378861 Show fit | 25.44 |
ENSRNOT00000091044
|
ankyrin 3 |
|
chrX_+_159158194 Show fit | 24.12 |
ENSRNOT00000043820
ENSRNOT00000001169 ENSRNOT00000083502 |
four and a half LIM domains 1 |
|
chr3_+_55910177 Show fit | 23.41 |
ENSRNOT00000009969
|
kelch-like family member 41 |
|
chr3_+_113318563 Show fit | 22.44 |
ENSRNOT00000089230
|
creatine kinase, mitochondrial 1 |
|
chr3_+_80075991 Show fit | 21.39 |
ENSRNOT00000080266
|
protein kinase C and casein kinase substrate in neurons 3 |
|
chr4_-_51199570 Show fit | 20.89 |
ENSRNOT00000010788
|
solute carrier family 13 member 1 |
|
chr8_+_33514042 Show fit | 18.03 |
ENSRNOT00000081614
ENSRNOT00000081525 |
potassium voltage-gated channel subfamily J member 1 |
|
chr3_+_56355431 Show fit | 17.88 |
ENSRNOT00000037188
|
myosin IIIB |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.4 | 44.2 | GO:0031427 | response to methotrexate(GO:0031427) |
2.6 | 29.1 | GO:0030049 | muscle filament sliding(GO:0030049) |
6.4 | 25.4 | GO:1900827 | positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.5 | 24.1 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
1.7 | 23.4 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) regulation of myoblast proliferation(GO:2000291) |
1.1 | 21.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
6.3 | 19.0 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
6.0 | 18.0 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
2.9 | 17.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 16.8 | GO:0021549 | cerebellum development(GO:0021549) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 48.2 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.4 | 46.3 | GO:0005901 | caveola(GO:0005901) |
1.9 | 29.1 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 26.7 | GO:0014069 | postsynaptic density(GO:0014069) |
2.5 | 25.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 24.8 | GO:0005925 | focal adhesion(GO:0005925) |
0.3 | 24.4 | GO:0045095 | keratin filament(GO:0045095) |
1.8 | 23.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 22.4 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 19.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 47.0 | GO:0000146 | microfilament motor activity(GO:0000146) |
5.5 | 44.2 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 25.4 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
3.2 | 22.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 22.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
1.9 | 21.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
4.5 | 18.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.6 | 17.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.4 | 16.5 | GO:0030507 | spectrin binding(GO:0030507) |
5.3 | 15.9 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 19.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 15.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.6 | 14.9 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 14.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.3 | 14.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.5 | 14.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 13.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 11.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.5 | 10.9 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 9.6 | PID FGF PATHWAY | FGF signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 44.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
1.0 | 37.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.7 | 25.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.5 | 20.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.4 | 14.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.4 | 12.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.7 | 11.5 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.2 | 11.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.5 | 10.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.7 | 10.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |